Advanced Flower Capital (AFCG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for May 28, 2026, with voting available online or virtually until May 27, 2026, 11:59 PM ET.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two directors: Alexander C. Frank and Marnie Sudnow, both recommended by the board.
Ratification of CohnReznick LLP as independent registered public accounting firm for the year ending December 31, 2026.
Board of directors and corporate governance
Board recommends both director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Advanced Flower Capital
- Q2 2026 net investment income was $0.15/share, NAV rose to $8.25, but non-accruals hit 22.7%.AFCG
Q2 2026 - All proposals passed, including director reelections and auditor ratification.AFCG
AGM 2026 - Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 2026 - Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCG
Investor presentation - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing - BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCG
Q4 2025 - Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 2025 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 2024 - Q1 2025 net income $4.1M, $0.21/share Distributable Earnings, $0.23 dividend, 18% yield.AFCG
Q1 2025